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Background: Galanin is expressed in a small percentage of intact small diameter sensory neurons of the dorsal
root ganglia and in the afferent terminals of the superficial lamina of the dorsal horn of the spinal cord. The
neuropeptide modulates nociception demonstrating dose-dependent pro- and anti-nociceptive actions in the naïve
animal. Galanin also plays an important role in chronic pain, with the anti-nociceptive actions enhanced in rodent
neuropathic pain models. In this study we compared the role played by galanin and its receptors in mechanical
and cold allodynia by identifying individual rat C-fibre nociceptors and characterising their responses to mechanical
or acetone stimulation.
Results: Mechanically evoked responses in C-fibre nociceptors from naive rats were sensitised after close intra-arterial
infusion of galanin or Gal2-11 (a galanin receptor-2/3 agonist) confirming previous data that galanin modulates
nociception via activation of GalR2. In contrast, the same dose and route of administration of galanin, but not Gal2-11,
inhibited acetone and menthol cooling evoked responses, demonstrating that this inhibitory mechanism is not
mediated by activation of GalR2. We then used the partial saphenous nerve ligation injury model of neuropathic pain
(PSNI) and the complete Freund’s adjuvant model of inflammation in the rat and demonstrated that close intra-arterial
infusion of galanin, but not Gal2-11, reduced cooling evoked nociceptor activity and cooling allodynia in both
paradigms, whilst galanin and Gal2-11 both decreased mechanical activation thresholds. A previously described
transgenic mouse line which inducibly over-expresses galanin (Gal-OE) after nerve injury was then used to investigate
whether manipulating the levels of endogenous galanin also modulates cooling evoked nociceptive behaviours
after PSNI. Acetone withdrawal behaviours in naive mice showed no differences between Gal-OE and wildtype (WT)
mice. 7-days after PSNI Gal-OE mice demonstrated a significant reduction in the duration of acetone-induced
nociceptive behaviours compared to WT mice.
Conclusions: These data identify a novel galaninergic mechanism that inhibits cooling evoked neuronal
activity and nociceptive behaviours via a putative GalR1 mode of action that would also be consistent with a TRP
channel-dependent mechanism.
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Galanin is expressed at low levels in less than 5% of
adult rodent dorsal root ganglia (DRG) neurons; those
expressing galanin are predominantly small diameter C-
fibre nociceptors. Higher levels of the neuropeptide are
expressed in the primary afferent terminals in the super-
ficial layers of the dorsal horn in naïve animals [1].
Levels of galanin in the rodent, primate and human
DRG markedly rise after peripheral nerve injury [1,2].
Administration of galanin to either the peripheral [3] or
central [4] nervous systems results in a significant alter-
ation in mechanosensory nociceptive behaviours. These
actions are dose-dependent with facilitation occurring
at low concentrations and inhibition at higher con-
centrations [3,4]. After nerve injury, when a subset of
mechano-nociceptors are sensitised to mechanical stim-
ulation [5] and the endogenous levels of galanin in the
DRG are high, there is good agreement in the literature
that the anti-nociceptive actions of galanin are enhanced
in rodent models of neuropathic pain [6]. In contrast to
the extensive dataset on galanin modulation of mechan-
osensory behaviours, there have been few studies on
galanin and cold behaviours. Work to date has shown
that in the naïve uninjured animal intrathecal infusion
of low dose galanin facilitates cold nociceptive behav-
ioural responses [7]. In contrast, in a model of neuro-
pathic pain galanin is anti-nociceptive, attenuating cold
pain [8].
The nociceptive effects of galanin are mediated by the
activation of one or more of three G-protein coupled gal-
anin receptor subtypes, designated GalR1, GalR2 and
GalR3. Studies using in-situ hybridization have shown that
GalR1 and GalR2 mRNAs are expressed by 51% and 83%
of adult rat DRG neurons respectively [9], and the levels of
both sub-types decrease after nerve injury [10,11]. In con-
trast, no change in the expression of either subtype was
observed in the dorsal horn of the spinal cord after axot-
omy [12]. Expression of GalR3 in the spinal cord and DRG
in both rat and mouse is very low as determined by RT-70
PCR [13,14], and in situ hybridization [15]. We and others
have shown that the central and peripheral anti-nocicep-
tive effects of galanin on mechanosensory thresholds are
principally mediated by activation of GalR1 [7] and GalR2
[3], respectively. Only two papers have studied which of
the galanin receptors mediate the effects of galanin on cold
nociception. Liu et al. showed that intrathecal infusion of
low dose Gal2-11 (a GalR2/3-specific agonist) increased
nociceptive responses to acetone in the naive rat, similar
to that seen with galanin [7]. In contrast, Blakeman et al.
demonstrated an increase in cold pain scores in naive
GalR1-KO mice compared to strain-matched wild-type
(WT) controls [16].
Here we investigated the role that galanin and its
receptors play at the primary afferent with particularreference to cold sensitivity, demonstrating that close
intra-arterial administration of galanin inhibits C-fibre
nociceptor cooling activity in normal, nerve-injured and
inflamed animals. These actions appear to be independ-
ent of GalR2 activation. These data identify a novel gala-
ninergic mechanism that inhibits cooling-evoked neuronal
activity and nociceptive behaviours consistent with a TRP
channel-dependent mechanism.
Results
Using multi-unit recordings in naive rats and models of
neuropathic and inflammatory pain, we studied the dif-
ferential effects of galanin and the GalR2/3-specific
agonist Gal2-11 on primary afferent nociceptor activities
to mechanical and cooling stimulation.
Differential effects of galanin and Gal2-11 on naïve
primary afferent nociceptor activities to mechanical and
cooling stimulation
Galanin 100 μM was administered via c.i.a. (close intra-
arterial) as previously described [17]. Mechanical activa-
tion thresholds were significantly reduced following gala-
nin administration (Figure 1A, ***p< 0.001) and
mechanically evoked activity was enhanced (Figure 1B, **
p< 0.01). Similarly, c.i.a. administration of 100 μM Gal2-
11 led to a significant reduction in activation thresholds
of mechanically sensitive C-fibre afferents (Figure 1C, **p
< 0.01) and an increase in mechanically evoked activity
(Figure 1D, *p< 0.05).
Application of acetone, which leads to mild nociceptive
behaviours in naïve rodents [18], reduced skin
temperature for approximately 30–60 seconds by ~5°C
from a resting temperature of ~25°C (Figure 2A). Room
temperature saline was used to confirm that the me-
chanical application of a drop of fluid to the receptive
field did not alter skin temperature (Figure 2A) or neu-
ronal responses (Figure 2B). On-going neuronal activity
in cooling primary afferents (as previously described
[19]), was identified from the application of room tem-
perature saline (Figures 2B and 3A). All cooling sensitive
afferents had CVs less than 1 m/s and were thus classi-
fied as cooling sensitive C-fibres. Application of acetone
to the receptive field significantly increased afferent
evoked activity compared to room temperature saline
(Figures 2B & 3A *p< 0.05, **p< 0.01 one way ANOVA).
Acetone responses following c.i.a. 100 μM galanin were
significantly reduced (Figures 2B & 2D, * p< 0.05 Paired t-
test). In contrast, 100 μM Gal2-11 had no effect on ace-
tone evoked responses (Figures 3A and 3C).
We then investigated the effects of galanin and Gal2-
11 on the neuronal activity elicited after application of
the cooling agent menthol; an activator of the cold sensi-
tive channel TRPM8 [20]. Menthol evoked action poten-
tials in 8 out of 10 acetone/cooling sensitive afferents. A
Figure 1 Facilitatory actions of galanin via activation of GalR2 on mechano-nociceptor afferents [A] Mechanical activation thresholds were
reduced by c.i.a 100 μM galanin in naïve rats (*** p< 0.001 Mann Whitney test, n = 24) and [B] mechanically evoked activity was increased by c.i.a
100 μM galanin in response to a 10 g vF hair mechanical stimulus (**p< 0.01 paired t-test). [C] Mechanical activation thresholds were reduced
following c.i.a 100 μM Gal2-11 administration (** p< 0.01 Mann Whitney test, n = 14) and [D] mechanically evoked activity was increased by c.i.a
100 μM Gal2-11 in response to a 10 g vF hair mechanical stimulus (* p< 0.01 paired t-test, n = 14).
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robust increase in evoked activity (Figure 4A) which was
significantly reduced when preceded by c.i.a administra-
tion of 100 μM galanin (Figure 4B, *p< 0.05 one way
ANOVA) but not by c.i.a 100 μM Gal2-11 (Figure 4B).
Differential effects of galanin and Gal2-11 on primary
afferent nociceptor activities to mechanical and cooling
stimulation in chronic pain models
In rats that had undergone PSNI that results
in mechanical and cold allodynia, c.i.a. 100 μM galanin and
c.i.a 100 μM Gal2-11 both led to a significant reduction in
mechanical activation thresholds of C-fibres (Figure 5A,
***p< 0.001). In contrast, acetone-evoked activity in C-fibre
afferents was significantly attenuated following c.i.a 100 μM
galanin (Figure 5B, *p< 0.05, ***p< 0.001) but not by c.i.a
100 μM Gal2-11 (Figure 5B).
A previously described transgenic mouse line which
inducibly over-expresses galanin (Gal-OE) after nerve in-
jury [21] was used to investigate whether manipulating
the levels of endogenous galanin also modulates cooling
evoked nociceptive behaviours after PSNI. We have
previously shown a marked attenuation of mechanical
allodynia in these mice after PSNI [3,21]. Acetone with-
drawal behaviours in naive mice showed no differences
between Gal-OE and WT mice. 7-days after PSNI Gal-
OE mice demonstrated a significant reduction in theduration of acetone-induced nociceptive behaviours
compared to WT mice (Figure 5C, *p< 0.01 two way
ANOVA).
Similar responses were also observed following CFA
treatment in the rat. The degree of inflammation at
5 days was confirmed by measuring ankle joint swelling
(Figure 6A, ***p< 0.001, paired t-test). 100 μM galanin
and 100 μM Gal2-11 by c.i.a administration both led to a
significant reduction in mechanical activation thresholds of
mechanically sensitive C-fibres (Figure 6B, **p< 0.01, ***p
< 0.001). In contrast, c.i.a 100 μM galanin, but not c.i.a
100 μM Gal2-11, attenuated the acetone evoked responses
in cooling sensitive C-fibres (Figure 6C, *p< 0.05 one
way ANOVA).
Discussion
This study describes the differential roles played by gala-
nin in the peripheral nervous system with respect to
mechanical- and cold-pain behaviours in the naive state
and following models of neuropathic and inflammatory
pain. Here we show opposing actions of galanin, with in-
hibition of cold- and facilitation of mechanical-responses,
in C-fibre nociceptors.
Cold allodynia (the sensation of pain to a normally in-
nocuous stimulus) is a common complaint of patients
with neuropathic pain, irrespective of the underlying
cause [22-24] and similar findings are found in a range
Figure 2 Exogenous galanin attenuates cooling responses. [A] Digitised trace of recording of subcutaneous skin temperature of the dorsal
surface of the rat hindpaw. Room temperature saline did not alter skin temperature. Application of acetone led to a reduction in skin temperature.
This returned to normal within 100 seconds. A second application of acetone again resulted in a similar drop in temperature. [B] Acetone
application to the receptive field of an identified cooling sensitive primary afferent led to a significant increase in neuronal firing, which was
significantly greater than the control application of room temperature saline (**p< 0.01 one way ANOVA with post-hoc Bonferroni test, n = 6).
Cooling evoked activity was significantly inhibited following administration of c.i.a. 100 μM galanin (*p< 0.05 Paired t-test, n = 6). [C] Example
trace of an acetone/cooling sensitive C fibre in response to room temperature saline. [D] Example trace of an acetone/cooling sensitive C fibre.
[E] Acetone evoked activity was attenuated in the same C fibre by c.i.a. 100 μM galanin. AP = action potential, AP number events = total number
of action potentials occurring per second.
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behaviours following stimulation with acetone or men-
thol [25-28]. Cooling detection in humans is highly vari-
able. It occurs after a drop in temperature of only a few
degrees [29,30] and is highly correlated with the activa-
tion temperature of TRPM8 [31-33] (31-27°C). Cold pain
thresholds are also highly variable, but are usuallyreported at lower temperatures [31,34] (<10°C). Patients
with neuropathic pain report pain after only a small re-
duction in skin temperature with thresholds reported
to be >20°C [35]. At these temperatures, symptoms are
described as painful with intense pain occurring at lower
temperatures [23] (~15°C). Recent work has made con-
siderable progress in defining the molecular transducers
Figure 3 Acetone evoked activity is not inhibited by GalR2/3 activation. [A] c.i.a. 100 μM Gal2-11 did not alter acetone-induced cooling
responses (n = 6). [B] Example trace of an acetone/cooling sensitive C fibre. [C] The acetone evoked activity was not altered by Gal2-11.
AP = action potential, AP number events = total number of action potentials occurring per second.
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underlie cold allodynia. A number of thermal sensors
have been identified which all belong to the Transient
Receptor Potential (TRP) ion channel family. The best
characterised cold receptor is TRPM8 [36-38]. TRPA1
was proposed as a noxious cold sensor but more recent
evidence has disputed a specific contribution for TRPA1
in cold transduction [28,39,40]. TRPM8 is expressed by a
subpopulation of small diameter C-fibre neurons [41].
TRPM8 responds to cooling agents such as acetone
with an activation temperature threshold of ~26°C, with
activity increasing in magnitude down to 8°C [36,38].
Menthol activates TRPM8 [42] and does not influence
TRPA1 activity in non-human mammals [20,43,44]. Con-
sistent with these findings, behavioural nociceptive
responses over a range of innocuous and noxious tem-
peratures and to the application of menthol are atten-
uated in TRPM8-KO mice, whereas these responses
remain intact in the TRPA1-KO [39].
In the present study we have shown that galanin, but
not Gal2-11, inhibits acetone and menthol responses in
the naive rodent and following models of neuropathic
and inflammatory pain. Similarly, overexpression of gala-
nin after nerve injury in the DRG of Gal-OE mice led to
the inhibition of cooling pain responses compared to
those of wild type mice, confirming that high levels of
endogenous galanin also inhibit cooling behaviours. The
modulatory effects of galanin on cooling are independent
of GalR2 and GalR3 activation since Gal2-11, which isequally selective for GalR2 and GalR3 [45], does not in-
hibit cooling pain behaviours. Further, since GalR3 is
expressed at very low levels in the primary nociceptor in
the intact and injured state [14], these findings imply the
effects of galanin on cold responses are mediated by acti-
vation of GalR1. These findings are consistent with our
work on the Gal-KO [46] and that of Blakeman et al.
which demonstrate an increase in cold pain scores in
naive GalR1-KO mice compared to strain-matched wild-
type (WT) controls [16].
Since galanin suppresses the effects of acetone and
menthol and the majority of acetone-sensitive C-fibres
were also activated by c.i.a administration of menthol,
this implies a mechanism via the modulation of the
TRPM8 cold sensor. To date, no publication has investi-
gated the effects of galanin and its receptors on TRPM8
activity. However, peripheral administration of galanin
has been shown to modulate TRPV1 (Transient Receptor
Potential Vanilloid) activity following inflammation, as
GalR1-activation inhibits capsaicin-evoked pain behav-
iours [47], whilst GalR2-activation facilitates the same
nociceptive responses [48]. Of note, all three galanin
receptors couple to Gi/o and inhibit adenylyl cyclase
[49,50], whilst GalR2 also signals via Gq/11 to activate
phospholipase C (PLC) and protein kinase C (PKC) [51].
Previous work has shown that TRPM8 activity in the DRG
is inhibited by the Gi/o adenylyl cyclase pathway [52],
which is again consistent with a GalR1-dependent modula-
tion of the channel.
Figure 4 Menthol evoked activity is not inhibited by GalR2/3
activation. [A] The concentration response relationship
demonstrates that acetone sensitive C fibres responds only to c.i.a.
100 mM menthol (***p< 0.001, one way ANOVA with post-hoc
Bonferroni test, n = 4). [B] Menthol evoked activity was reduced by c.i.a.
100 μM galanin but not by c.i.a. 100 μM Gal2-11 (* p< 0.05, one way
ANOVA with post-hoc Bonferroni test, n = 7).
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administration of galanin on cooling nociception, here
we show that c.i.a administration of the same dose
(100 μM) of galanin and Gal2-11 both facilitate mechano-
sensory responses. The nature and magnitude of these
changes (Figure 1) are very similar to our previously pub-
lished dataset using injection of 100nM galanin or 100nM
Gal2-11 directly into the afferent receptive field in naïve
adult male rats [3] (Figures 1, 5A and 6B in that paper).
This implies that the local concentration of galanin or
Gal2-11 at the nociceptor is ~1000-fold lower than that
administered by c.i.a bolus injection which may be
explained by a combination of dilution of the peptides by
the blood volume of the hind limb and only partial tissue
penetration of the peptides. Our current and previous
findings confirm that the peripheral mechano-nociceptive
effects of galanin appear to be predominantly dependent
on activation of GalR2, in contrast to the effects of galanin
administered intrathecally which appear to be mediated by
activation of GalR1 [7].In conclusion, peripheral administration of galanin, but
not Gal2-11, inhibits acetone- and menthol-evoked activ-
ity in C-fibre nociceptors in the normal animal and in
models of neuropathic and inflammatory pain. These
data identify a novel putative GalR1-dependent pathway
that inhibits cooling-evoked neuronal activity and noci-
ceptive behaviours, consistent with a TRPM8-dependent
mechanism. Taken together with the known peripheral
GalR2-dependent modulation of mechano-nociception,
these findings imply that activation of peripheral GalR1
and GalR2 will both be important to treat cold and




Experiments were performed on adult male Wistar rats
(250 g-350 g) and mice (~25 g). 47 Wistar rats were
used for electrophysiological experiments. 10 transgenic
mice that inducibly over-express galanin in the DRG as
previously described [3], and 10 matched WT controls
were used in nociceptive behavioural testing. Animals
were fed standard chow and water ad libitum and all
experiments were carried out in accordance with the
United Kingdom Animals (Scientific Procedures) Act
1986.
Electrophysiological recordings
Anaesthesia was induced using sodium pentobarbital
(60 mg/kg i.p. rats, Sigma-Aldrich, UK) and were main-
tained deeply anaesthetised and areflexive for the dur-
ation of the experiment (~20 mg/kg/hr, sodium
pentobarbital delivered intravenously via cannulation of
the external jugular vein). A tracheotomy was performed
to maintain the airway. Monitoring of blood pressure
was carried out via a femoral artery cannulation of the
left hind limb. Rodent body temperature was maintained
at ~37.5°C by means of a feedback controlled heater and
rectal thermistor. At the end of all experiments, rats
were overdosed with a single large bolus of (60 mg/ml)
sodium pentobarbital.
An incision was made along the inguinal fossa of the
right hind leg to expose the saphenous nerve which
runs superficially under the skin adjacent to the fem-
oral vasculature. Using blunt dissection, connective
tissue was removed and the skin was freed. Using the
skin a pool was formed by attaching the skin to a
metal pool ring, which was filled with warmed mineral
oil (Sigma-Aldrich, UK). Fine forceps were used to dis-
sect out a sufficient length of the nerve that was
placed onto a dental mirror. The main saphenous
nerve trunk was further prepared by removing the sur-
rounding epineurium. Fine filaments were dissected
out and cut proximally. These nerve filaments were
Figure 5 Differential role of galanin in a model of neuropathic pain [A] Exogenous c.i.a 100 μM galanin and c.i.a 100 μM Gal2-11 both
facilitated mechano-nociceptor responses in the partial saphenous nerve injury model of neuropathic pain (** p< 0.01, *** p< 0.001, Kruskal
Wallis test with Dunn’s multiple comparison test, galanin n= 15, Gal2-11 n = 6). [B] In the PSNI neuropathic pain model acetone application to the
receptive field of cold sensitive C fibres led to a significant increase in evoked activity (***p< 0.001, Kruskal-Wallis with Dunn’s multiple
comparison test). Acetone-induced evoked activity was inhibited by c.i.a 100 μM galanin but was not altered by c.i.a 100 μM Gal2-11 (***p< 0.001,
one way ANOVA with post-hoc Bonferroni test, n = 10) [C] Acetone-induced withdrawal behaviours in naïve Gal-OE transgenic mice did not differ
from WT controls. 7-days after nerve injury the Gal-OE mice demonstrated a significant reduction in cooling pain like behaviours compared to
matched WT mice (*p< 0.01, two way ANOVA with post-hoc Bonferroni test, n = 7).
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record from individual afferent responses. Identified
fine nerve filaments were ensured to have a lownumber of responsive receptive fields in the hindpaw
(<3), with these receptive fields not overlapping. The
neuronal activity of individual afferents was captured
Figure 6 Differential role of galanin in CFA inflammation [A]
CFA inflammation was confirmed through significant ipsilateral ankle
joint swelling compared to the contralateral joint (***p< 0.001,
paired t-test, n = 6). [B] Exogenous c.i.a. 100 μM galanin and c.i.a.
100 μM Gal2-11 both significantly facilitated mechano-nociceptor
mechanical responses in CFA inflamed rats (** p< 0.01,
*** p< 0.001, Kruskal-Wallis with Dunns multiple comparison test,
n = 9). [C] Exogenous c.i.a. 100 μM galanin, but not c.i.a. 100 μM
Gal2-11, reduced acetone evoked activity (* p< 0.05, one way
ANOVA with post-hoc Bonferroni, n = 6).
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software (C.E.D. Cambridge, UK).
Afferent characterisation
Primary afferents were identified using search stimuli of
both blunt/pinch mechanical stimulation of the medialsurface of the hindpaw, and electrical stimulation. Each
afferent identified was characterised with the same
protocol as described below. Upon identification of a re-
ceptive field the conduction velocity (CV) for the affer-
ent was recorded. Electrical stimulation of the receptive
field (0.5 ms stimulus duration, up to 100 V, every 3 sec-
onds) was used to calculate the conduction velocity of
the afferent. Three or more robust CVs from the recep-
tive field were required to confirm reproducibility and
confirmation of afferent excitation. CVs less than 1 m/s
were classed as C fibres, those with greater than 1 m/s
as A fibres [53]. On-going neuronal activity was moni-
tored for 100 seconds following CV characterisation.
This 100 second period recorded any neuronal activity
from the afferent that occurred without any stimulus
being applied to the receptive field. Mechanical re-
sponses were recorded using calibrated plastic filaments;
von Frey hairs (Linton Instruments, UK) and brush
stimulation. Von Frey hairs (vF) were used to elicit
mechanical responses, with each vF hair applied three
times for a maximum of five seconds. The mechanical
activation threshold was determined using an adapted up
and down method, and the lowest vF hair that elicited a
robust response (response >3 action potentials) was
noted as the activation threshold [54]. Afferents were
also tested for innocuous cooling responses. Acetone was
applied to the receptive field to test for cooling
responses. This stimulus leads to withdrawal behaviours
[55] and is a standard tool to excite cooling neuronal
responses [56,57]. Prior to acetone, a single drop of room
temperature saline was applied (using a Gilson and 1 ml
pipette tip) to the receptive field to identify any mechan-
ical response occurring due to the application of a drop
of fluid. Neuronal activity was recorded for 30 seconds
post stimulation. Room temperature saline and acetone
were each applied a total of 3 times with 5 minutes be-
tween each application to allow skin temperature and
neuronal activity to recover to baseline levels. Mean
acetone and saline evoked responses were calculated. To
note, cooling afferent groups studied with drug adminis-
tration include both CCs (cold sensitive C fibres) and
CMCs (mechano-cold sensitive C fibres) as previously
described [58,59]. Drug responses were not different be-
tween these two groups.
Experimental protocol and drug administration
Following baseline mechanical and cooling characterisation
of primary afferent fibres, drugs were administered via the
close intra-arterial (c.i.a) route as previously described
[17,60]. The left femoral artery was cannulated in the groin
and the cannula was advanced proximally, approximately
~2.5 cm, towards the bifurcation of the descending aorta.
Cannula positioning was confirmed by visual inspection
upon termination of experiment. Menthol (Sigma-Aldrich),
Hulse et al. Molecular Pain 2012, 8:41 Page 9 of 11
http://www.molecularpain.com/content/8/1/41100 μM galanin (Bachem) or 100 μM Gal2-11 (Sigma-
Aldrich, UK), were made up in saline and injected and
washed through the c.i.a. cannula with 400ul of saline
(containing heparin 50units/ml). 5 minutes after galanin or
Gal2-11 injection either mechanical, acetone and menthol
responses were tested. Since galanin and Gal2-11 have
short half-life of <10 minutes [46,61], in some experi-
ments galanin and Gal2-11 were tested sequentially in the
same animal to reduce the number of animals used. 30
minutes was allowed between peptides to allow for metab-
olism and removal. 100 mM menthol (Sigma-Aldrich, UK)
was administered via c.i.a cannula as previously described
[28,55,60]. Menthol was dissolved in 10% ethanol, 10%
Tween80 and 80% saline and vehicle alone had no effect
on neuronal activity (data not shown).
Temperature recordings
A thermocouple was advanced under the skin of the
medial surface of the hindpaw using a 25-gauge needle.
The thermocouple was used to identify changes in skin
temperature following application of various stimuli. Sa-
line and acetone were applied and temperature changes
monitored and recorded using a CED micro 1401 and
Spike2 software as described previously [56].
Chronic pain models
For all recovery surgeries; partial saphenous nerve ligation
injury (PSNI) and complete Freund’s adjuvant (CFA), an-
aesthesia was induced using 4% halothane in oxygen and
maintained with 2-3% for all procedures.
PSNI surgery
The PSNI surgery was performed as previously described
[57,62] on 19 male wistar rats and 20 male mice, leading
to the characteristic neuropathic pain phenotypes of
mechanical allodynia and cooling allodynia [57,62,63].
An incision was made along the inguinal fossa of the
right hind leg and the saphenous nerve was isolated
using blunt dissection. A sterile silk suture (mouse: 7.0
suture and rat: 4.0 suture) was used to tightly ligate 50%
of the saphenous nerve. The skin incision was closed
using size 4.0 sutures. The animals were allowed to re-
cover and monitored for the duration of the experiment.
Electrophysiological experimentation was performed
7 days after PSNI surgery.
Complete freunds adjuvant (CFA) inflammation
Two 50 μl injections of CFA (1 mg/ml, Sigma-Aldrich,
UK), one on either side of the tibio-tarsal ankle joint,
were used to induce inflammation in nine male Wistar
rats as previously described [60] for electrophysiological
experimentation and left to develop for five days. This
intervention leads to significant swelling of the ankle and
hindpaw [64].Animal behaviour
Mice were habituated to behavioural testing enclosures
(mesh floored holding chambers) the day prior to testing
for 15 minutes. For testing days animals were placed into
behavioural enclosures 10 minutes prior to testing. Using a
1 ml syringe, acetone was applied to the plantar surface of
the hindpaw. The duration of flinching/pain like behaviour
(seconds) was recorded immediately following acetone ap-
plication for a total period of five minutes. This was per-
formed three times for each hindpaw, from which the
mean was calculated. Stimulations of the right and left
hindpaw were alternated to prevent sensitisation and allow
recovery of skin temperature. Baselines were taken for two
separate recording sessions and were then used to generate
the baseline timepoint. Seven days post nerve injury ani-
mals were re-tested for acetone responses.
Statistical analysis
Paired t-test and one way ANOVA with post-hoc Bonfer-
roni tests were used to determine primary afferent evoked
activity to mechanical or cooling stimulation before and
after drug, as appropriate (galanin, Gal2-11 and menthol,
*p< 0.05, **p< 0.01, ***p< 0.001). Mechanical activation
threshold was determined by Mann Whitney Test or
Kruskal-Wallis test with Dunns multiple comparison test
(*p< 0.05, **p< 0.01, ***p< 0.001). To determine if gala-
nin or Gal2-11 facilitated mechanical responses
(increased number of action potentials) to an evoked
stimulus, a cut off was set as two standard deviations
above and below the mean of the evoked activity. In
addition, cooling sensitive primary afferent evoked activ-
ity in response to acetone was calculated through a fold
change in activity compared to that following room
temperature saline application. Percentage change of cold
induced pain like behavioural responses following PSNI
were calculated from baseline naïve animal responses.
Two way ANOVA with post bonferroni tests was used to
determine differences in the Gal-OE cooling behaviour
analysis. All data are presented as mean± SEM.
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